Stevens-Johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin

被引:5
|
作者
Maciejewska, Jolanta [1 ]
Jankowski, Marek [1 ]
Zegarska, Barbara [2 ]
Czajkowski, Rafal [1 ]
机构
[1] Nicolaus Copernicus Univ Torun, Ludwik Rydygier Med Coll Bydgoszcz, Dept Dermatol Sexually Transmitted Dis & Immunode, PL-85094 Bydgoszcz, Poland
[2] Nicolaus Copernicus Univ Torun, Ludwik Rydygier Med Coll Bydgoszcz, Dept Cosmetol & Esthet Dermatol, PL-85094 Bydgoszcz, Poland
来源
POSTEPY DERMATOLOGII I ALERGOLOGII | 2014年 / 31卷 / 03期
关键词
Stevens-Johnson syndrome; toxic epidermal necrolysis; norfloxacin; CIPROFLOXACIN; MANAGEMENT;
D O I
10.5114/pdia.2014.40796
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare mucocutaneous, unpredictable, life-threatening drug side reactions. A very rare case of norfloxacin-induced SJS/TEN overlap with uncommon clinical presentation in a patient with a suspected urinary tract infection is reported. The SJS/TEN management with possible treatment capabilities are discussed. In spite of only two previous reports of norfloxacin-induced SJS and TEN we believe that awareness of norfloxacin adverse reactions needs to be raised among prescribers.
引用
收藏
页码:194 / 196
页数:3
相关论文
共 50 条
  • [1] Toxic epidermal necrolysis and Stevens-Johnson syndrome
    Thomas Harr
    Lars E French
    Orphanet Journal of Rare Diseases, 5
  • [2] Stevens-Johnson syndrome and toxic epidermal necrolysis
    Borchers, Andrea T.
    Lee, Jennifer L.
    Naguwa, Stanley M.
    Cheema, Gurtej S.
    Gershwin, M. Eric
    AUTOIMMUNITY REVIEWS, 2008, 7 (08) : 598 - 605
  • [3] Toxic epidermal necrolysis and Stevens-Johnson syndrome
    Hussain, W
    Craven, NM
    CLINICAL MEDICINE, 2005, 5 (06) : 555 - 558
  • [4] STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS
    Laguna, Cecilia
    Martin, Blanca
    Torrijos, Arantxa
    Garcia-Melgares, Maria L.
    Febrer, Isabel
    ACTAS DERMO-SIFILIOGRAFICAS, 2006, 97 (03): : 177 - 185
  • [5] Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Chronopoulos, A.
    Pleyer, U.
    Mockenhaupt, M.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2012, 229 (05) : 534 - 539
  • [6] Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Spectrum for the Rheumatologist
    Parida, Jyoti Ranjan
    Tripathy, Saumya Ranjan
    INDIAN JOURNAL OF RHEUMATOLOGY, 2019, 14 : S67 - S75
  • [7] Stevens-Johnson syndrome and toxic epidermal necrolysis: a review
    Wong, Anthony
    Malvestiti, Andrey Augusto
    Silva Hafner, Mariana de Figueiredo
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2016, 62 (05): : 468 - 473
  • [8] Toxic epidermal necrolysis and Stevens-Johnson syndrome: A review
    Gerull, Roland
    Nelle, Mathias
    Schaible, Thomas
    CRITICAL CARE MEDICINE, 2011, 39 (06) : 1521 - 1532
  • [9] An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children
    Koh, Mark Jean-Aan
    Tay, Yong-Kwang
    CURRENT OPINION IN PEDIATRICS, 2009, 21 (04) : 505 - 510
  • [10] Managing the ADR of Stevens-Johnson syndrome/toxic epidermal necrolysis
    Lian, Bertrand Sheng-Yang
    Lee, Haur Yueh
    EXPERT OPINION ON DRUG SAFETY, 2022, 21 (08) : 1039 - 1046